Litigation Details for Indivior Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Indivior Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-04-04 |
| Court | District Court, D. Delaware | Date Terminated | 2019-09-16 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 9,687,454; 9,855,221 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Indivior Inc. v. Actavis Laboratories UT, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Indivior Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-05-16 | 63 | Amended Answer to Complaint | 207387 to the FDA infringed claims of U.S. Patent No. 9,855,221. See, e.g., C.A. No. 18-497-RGA, D.I. 6.…the ’454 patent as the assignee. Defendant further admits that, on its face, the ’454 patent is titled… copy of the ’454 patent. Defendant avers that the allegation that the ’454 patent was duly and legally…are required to disclose to the FDA the patent numbers of patents claiming the drug or method of using … THE PATENT-IN-SUIT 12. The ’454 patent, entitled “Sublingual and Buccal | External link to document |
| 2019-09-16 | 73 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,687,454 B2. (nms) (Entered… 16 September 2019 1:18-cv-00499 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
